Art Taveras

Art Taveras

Geen lopende functies
62 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Dr. Art Taveras was previously employed as a Chief Scientific Officer by X4 Pharmaceuticals, Inc., a Chief Scientific Officer by Comet Therapeutics, Inc., a Chief Scientific Officer & Head-Drug Discovery by Transform Therapeutics, a President & Chief Scientific Officer by Shanghai ChemPartner Co., Ltd., a Vice President-Small Molecule Drug Discovery by Biogen Idec, Inc. (North Carolina), and a Vice President-Drug Discovery & Development by Alantos Pharmaceuticals Holding, Inc. He received his undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Rensselaer Polytechnic Institute and a doctorate degree from Rensselaer Polytechnic Institute.

Eerdere bekende functies van Art Taveras

BedrijvenFunctieEinde
X4 PHARMACEUTICALS, INC. Hoofd Techniek/Wetenschap/O&O 01-01-2025
Transform Therapeutics
Oprichter 01-11-2020
Hoofd Techniek/Wetenschap/O&O 01-07-2020
President 01-12-2014
Corporate Officer/Principal 01-01-2013
Ervaring van Art Taveras in detail bekijken

Opleiding van Art Taveras

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

10

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Transform Therapeutics

  1. Beurs
  2. Insiders
  3. Art Taveras